According to Microbot Medical 's latest financial reports the company's current earnings (TTM) are -$10.14 M. an increase over its 2022 earnings that were of -$13.29 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$10.14 M | -23.68% |
2022 | -$13.29 M | 16.94% |
2021 | -$11.36 M | 24.95% |
2020 | -$9.09 M | 27.23% |
2019 | -$7.15 M | -1.38% |
2018 | -$7.25 M | 37.54% |
2017 | -$5.27 M | -1023.57% |
2016 | $0.57 M | -101.59% |
2015 | -$35.91 M | 17.25% |
2014 | -$30.63 M | 21.18% |
2013 | -$25.28 M | |
2011 | -$27.14 M | -6.88% |
2010 | -$29.14 M | -0.82% |
2009 | -$29.38 M | 13.55% |
2008 | -$25.88 M | -6.96% |
2007 | -$27.81 M | 137.94% |
2006 | -$11.69 M | -28.69% |
2005 | -$16.39 M | 6.42% |
2004 | -$15.4 M | 26.79% |
2003 | -$12.15 M | 18.96% |
2002 | -$10.22 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$2.17 M | -78.68% | Bahamas |
NRC Health
NRC | $40.82 M | -502.75% | ๐บ๐ธ USA |